Literature DB >> 1462986

Iron accumulation in human chronic renal disease.

B J Nankivell1, R A Boadle, D C Harris.   

Abstract

Iron, which has been shown to accumulate within proximal tubule lysosomes in proteinuric models of renal disease, may play a role in the progression of chronic renal disease by the generation of reactive oxygen species. Therefore, renal biopsies from humans with proteinuria and/or chronic renal failure were examined at an ultrastructural level for iron by energy dispersive analysis and compared with normal biopsies. Iron accumulated in proximal tubular lysosomes in renal disease (P < 0.05 v normals), accompanied in some cases by phosphorus and silicon. Both the number of iron-containing lysosomes per tubular cross-section (1.86 +/- 0.41 v 0.66 +/- 0.22, P < 0.05) and the mean concentration of lysosomal iron (254.5 +/- 73.4 mg/dL v 81.2 +/- 23.8, P < 0.001) was greater in patients with nephrotic syndrome (n = 12) than in those without (n = 8). Iron accumulation (number of iron-containing lysosomes/tubule) correlated with protein excretion (r = 0.68, P = 0.003, n = 20), but not with glomerular filtration rate. Damaged tubules contained greater amounts of iron than tubules with less damage (288.5 +/- 68.5 mg/dL v 80.4 +/- 13.9, P < 0.01). Further studies are needed to define the possible role of iron in causing tubular damage and progression of renal disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1462986     DOI: 10.1016/s0272-6386(12)70222-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  23 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

Review 2.  Overview of iron metabolism in health and disease.

Authors:  Som Dev; Jodie L Babitt
Journal:  Hemodial Int       Date:  2017-03-15       Impact factor: 1.812

3.  Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease.

Authors:  Yoshiro Naito; Aya Fujii; Hisashi Sawada; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Akiyo Eguchi; Shinichi Hirotani; Tohru Masuyama
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

4.  Iron restriction inhibits renal injury in aldosterone/salt-induced hypertensive mice.

Authors:  Hisashi Sawada; Yoshiro Naito; Makiko Oboshi; Toshihiro Iwasaku; Yoshitaka Okuhara; Daisuke Morisawa; Akiyo Eguchi; Shinichi Hirotani; Tohru Masuyama
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

5.  Urinary NGAL marks cystic disease in HIV-associated nephropathy.

Authors:  Neal Paragas; Thomas L Nickolas; Christina Wyatt; Catherine S Forster; Meghan Sise; Susan Morgello; Bernd Jagla; Charles Buchen; Peter Stella; Simone Sanna-Cherchi; Maria Luisa Carnevali; Silvia Mattei; Achiropita Bovino; Lucia Argentiero; Andrea Magnano; Prasad Devarajan; Kai M Schmidt-Ott; Landino Allegri; Paul Klotman; Vivette D'Agati; Ali G Gharavi; Jonathan Barasch
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

6.  Iron, oxidative stress, and clinical outcomes.

Authors:  Rajiv Agarwal
Journal:  Pediatr Nephrol       Date:  2007-11-21       Impact factor: 3.714

7.  Ironing out the pathogenesis of acute kidney injury.

Authors:  Sangeeta Hingorani; Bruce A Molitoris; Jonathan Himmelfarb
Journal:  Am J Kidney Dis       Date:  2009-04       Impact factor: 8.860

8.  Iron chelator alleviates tubulointerstitial fibrosis in diabetic nephropathy rats by inhibiting the expression of tenascinC and other correlation factors.

Authors:  Chunbo Zou; Rujuan Xie; Yushi Bao; Xiaogang Liu; Manshu Sui; Suhong M; Shuang Li; Huiqing Yin
Journal:  Endocrine       Date:  2013-03-07       Impact factor: 3.633

Review 9.  Non transferrin bound iron: nature, manifestations and analytical approaches for estimation.

Authors:  Meghna Patel; D V S S Ramavataram
Journal:  Indian J Clin Biochem       Date:  2012-08-31

Review 10.  The Cross-Link between Ferroptosis and Kidney Diseases.

Authors:  Jingyu Wang; Yi Liu; Yaqing Wang; Li Sun
Journal:  Oxid Med Cell Longev       Date:  2021-05-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.